Skip to main content
Novonesis AS logo

Novonesis AS — Investor Relations & Filings

Ticker · NSIS ISIN · DK0060336014 LEI · 529900T6WNZXD2R3JW38 CO Manufacturing
Open in API
Filings indexed 2,308 across all filing types
Latest filing 2015-01-20 Report Publication Anno…
Country DK Denmark
Listing CO NSIS

About Novonesis AS

https://www.novozymes.com/en

Novonesis is a global biosolutions company formed through the combination of Novozymes and Chr. Hansen. The company develops and produces a broad portfolio of biological solutions, including industrial enzymes, functional proteins, and microorganisms such as cultures, probiotics, and yeast. Its products are utilized in over 30 industries to improve efficiency, sustainability, and product quality. Key markets include food and beverage, where solutions enhance nutrition and reduce waste; human and animal health; agriculture, promoting higher crop yields and animal welfare; and household care, for more effective cleaning. Novonesis applies biotechnological principles to address global challenges in production and consumption, aiming to create more sustainable systems and products.

Recent filings

Filing Released Lang Actions
Report Publication Announcement 2015
Report Publication Announcement Classification · 98% confidence The document text is extremely short ("Please read the report in PDF format") and does not contain the content of any specific financial report (like 10-K, IR, or ER). Instead, it explicitly directs the reader to an external PDF document. According to Rule 2 (The 'Menu vs Meal' Rule), a short announcement stating that a report is available elsewhere should be classified as a Report Publication Announcement (RPA).
2015-01-20 English
Annual Report 2015
Annual Report
2015-01-20 Danish
Earnings Release 2014
Earnings Release Classification · 99% confidence The document text contains detailed financial performance metrics for the full year 2014 (e.g., Salgsvækst, Resultat af primær drift, Overskudsgrad) and provides explicit forward-looking guidance for 2015 and long-term goals (Frem mod 2020). It includes comprehensive tables comparing realized results with expectations and discusses segment performance (Bioenergi, Vaskemidler, etc.) and geographical breakdown. The structure, detail level, and inclusion of CEO commentary strongly indicate a comprehensive annual financial report, which corresponds to the definition of a 10-K (Annual Report) in the US context, or the equivalent comprehensive annual filing in other jurisdictions. Although the text is in Danish, the content aligns perfectly with the scope of a 10-K. FY 2014
2015-01-20 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text is very short (144 characters) and states that Novozymes has completed an announced share buyback program ('aktietilbagekøbsprogram') totaling DKK 2.0 billion. It directs the reader to 'Læs hele meddelelsen i pdf format' (Read the full announcement in pdf format). This structure—a brief announcement stating an action is complete and pointing to a full document—fits the definition of a Report Publication Announcement (RPA) or potentially a Transaction in Own Shares (POS). Since the core content is the completion of a share repurchase, POS is the most specific fit, but given the 'MENU VS MEAL' rule, the text itself is an announcement *about* the transaction, not the detailed filing. However, POS is specifically defined as 'Report of the company buying back or selling its own shares (share repurchase/issuance)'. Because the text explicitly confirms the completion of the buyback, it is directly reporting the transaction event, making POS more appropriate than RPA, which is usually for announcing the *release* of a separate report. I will classify it as POS as it reports the transaction completion, despite its brevity.
2014-12-11 Danish
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that the company has 'completed the announced DKK 2 billion share buyback program.' This directly relates to the company repurchasing its own shares. The corresponding category is 'Transaction in Own Shares' (POS). Since the text is very short and directs the user to read the 'full announcement in PDF format,' it could potentially be an RPA, but the core subject matter is a completed share transaction, making POS the most specific classification for the *content* described, even if the delivery mechanism is a brief announcement.
2014-12-11 English
Transaction in Own Shares 2014
Transaction in Own Shares Classification · 100% confidence The document text explicitly states that Novozymes has purchased an accumulated number of shares under a 'stock buyback program'. This action directly corresponds to the definition of a company buying back its own shares. The appropriate filing type is 'Transaction in Own Shares' (POS). The document is very short (293 chars) and mentions reading the full announcement in PDF, which might suggest RPA, but the core content is a specific transaction report (buyback), making POS the primary classification, as it details the transaction itself rather than just announcing the publication of a report.
2014-12-05 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.